Brief: GoodRx Holdings Q3 Adjusted Net Income USD 28.8 Million Vs. IBES Estimate USD 32.6 Million
04/11/2025 21:05
Nov 04 (Reuters) - GoodRx Holdings Q3 revenue USD 196 million vs. IBES estimate USD 195.2 million. Q3 adjusted EBITDA USD 66.3 million vs. IBES estimate USD 64.6 million Q3 net income USD 1.1 million Q3 adjusted EBITDA margin 33.8%
Recent news on GoodRx Holdings
See all newsAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million